Show/Hide Menu

Investor information

Financial guidance 2016

MorphoSys expects Group revenues for the 2016 financial year in the range of EUR 47 to 52 million. R&D expenses for proprietary drug development are expected to rise to EUR 76 to 83 million. The Company expects earnings before interest and taxes (EBIT) in a range of between EUR -58 to -68 million. This guidance does not include any potential in-licensing or co-development of further development candidates.

 

in € million 2016 (estimated) 2015 (actual)
Group Revenues 47 to 52 106.2
R&D expenses Proprietary Development 76 to 83 56.6
Group EBIT -58 to -68 17.2

Fundamentals of
MorphoSys Group

Business Segments

MorphoSys is one of the world’s leading biotechnology companies focusing on fully human antibodies. With its proprietary technologies, MorphoSys is developing the next generation of therapeutic antibodies. MorphoSys is committed to create significant value for its employees, shareholders, customers and partners through a sustainable business strategy balancing short-term and long-term growth potentials. 

PARTNERED DISCOVERY

MorphoSys's Partnered Discovery segment business applies the Company's proprietary technologies to the research, development and optimization of therapeutic antibody drug candidates in partnerschips with pharmaceutical and biotechnology companies. While the development costs are borne by the respective partner, MorphoSys profits further from successful programs via milestone payments and potential royalties on product sales.

Please learn more about MorphoSys's partnered programs here.

PROPRIETARY DEVELOPMENT

In the second segment, Proprietary Development, MorphoSys develops innovative proprietary antibody products to generate added value for the Company. MorphoSys's scientists concentrate on indications such as inflammatory and autoimmune diseases, as well as cancer and infectious diseases. In this segment, the compounds are developed independently (or in a co-development setting) to proof clinical efficacy before being out-licensed to pharmaceutical or biotechnology companies for late-stage development and marketing.

More information about our proprietary product portfolio can be found here.

Related Links

Financial Reports

 
PDF-Download
Online Version
Order Printed Version

2016

  1. Half-Year Report 2016

    Download
    Online
    Order
     
  1. 1st Quarter Interim Statement 2016

    Download
    Online
    Order
     

2015

  1. Financial Statements 2015 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2015

    Download
    Online
    Order
     
  3. Nine Months' Report 2015

    Download
    Online
    Order
     
  4. Six Months' Report 2015

    Download
    Online
    Order
     
  5. Three Months’ Report 2015

    Download
    Online
    Order
     

2014

  1. Financial Statements 2014 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2014

    Download
    Online
    Order
     
  3. Nine Months' Report 2014

    Download
    Online
    Order
     
  4. Six Months' Report 2014

    Download
    Online
    Order
     
  5. Three Months' Report 2014

    Download
    Online
    Order
     

2013

  1. Financial Statements 2013 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2013

    Download
    Online
    Order
     
  3. Nine Months' Report 2013

    Download
    Online
    Order
     
  4. Six Months' Report 2013

    Download
    Online
    Order
     
  5. Three Months' Report 2013

    Download
    Online
    Order
     

2012

  1. Consolidated Financial Statements (IFRS) 2012

    Download
    Online
    Order
     
  2. Financial Statements 2012 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2012

    Download
    Online
    Order
     
  4. Six Months' Report 2012

    Download
    Online
    Order
     
  5. Three Months' Report 2012

    Download
    Online
    Order
     

2011

  1. Consolidated Financial Statements (IFRS) 2011

    Download
    Online
    Order
     
  2. Financial Statements 2011 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2011

    Download
    Online
    Order
     
  4. Six Months' Report 2011

    Download
    Online
    Order
     
  5. Three Months' Report 2011

    Download
    Online
    Order
     

2010

  1. Consolidated Financial Statements (IFRS) 2010

    Download
    Online
    Order
     
  2. Financial Statements 2010 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2010

    Download
    Online
    Order
     
  4. Six Months' Report 2010

    Download
    Online
    Order
     
  5. Three Months’ Report 2010

    Download
    Online
    Order
     

Investor Relations
Presentations

Date
Venue
Download

2016

  1. 09/22/2016
    Baader Investment Conference
  2. 09/20/2016
    Fifth Berenberg and Goldman Sachs Annual German Corporate Conference
  3. 09/15/2016
    Bank of America Merrill Lynch Global Healthcare Conference 2016
  4. 09/14/2016
    Morgan Stanley Global Healthcare Conference
  5. 09/13/2016
    J.P. Morgan London Small/Mid Cap Conference
  6. 09/09/2016
    Goldman Sachs Annual Biotech Symposium
  7. 08/30/2016
    Commerzbank Sector Conference 2016
  8. 06/23/2016
    J.P. Morgan European Healthcare Conference
  9. 06/10/2016
    Jefferies 2016 Global Health Care Conference
  10. 06/09/2016
    dbAccess German, Swiss & Austrian Conference
  11. 06/08/2016
    Goldman Sachs 37th Annual Global Healthcare Conference
  12. 06/07/2016
    ASCO 2016 Investors Event
  13. 05/23/2016
    UBS Global Healthcare Conference
  14. 05/09/2016
    Goldman Sachs European Small & Mid-Cap Symposium
  15. 05/05/2016
    Deutsche Bank 41st Annual Health Care Conference
  16. 04/07/2016
    Kempen & Co Life Sciences Conference
  17. 03/31/2016
    Oddo Biotech / Medtech Forum
  18. 03/10/2016
    Leerink Partners Annual Emerging Biotech Conference
  19. 03/02/2016
    Presentation Annual Financial Results 2015
  20. 01/14/2016
    J.P. Morgan 34th Annual Healthcare Conference

2015

  1. 12/07/2015
    ASH 2015 Investors Event
  2. 11/24/2015
    Deutsches Eigenkapitalforum 2015
  3. 11/18/2015
    Jefferies Autumn 2015 Global Healthcare Conference